Clopidogrel/aspirin - Hanmi PharmaceuticalAlternative Names: aspirin/clopidogrel - Hanmi Pharmaceutical
Latest Information Update: 16 Jul 2016
At a glance
- Originator Hanmi Pharmaceutical
- Class Antiplatelets; Antipyretics; Pyridines; Salicylic acids; Small molecules; Thienopyridines
- Mechanism of Action Cyclooxygenase inhibitors; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Acute coronary syndromes
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute coronary syndromes(In volunteers) in South Korea (PO)